All posts tagged
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
Novartis Negotiates its Way into the US Migraine Market
Novartis Gets Ready to Take on the EU Market with Two New Biosimilars
UPDATE: Novartis broadens CAR-T onslaught with FDA endorsement
Two Big Pharma Players Team up to Take Over the NASH Space
The Top 12 Biotech Leaders you should know in Basel
How is Biotech Transforming Pharma’s R&D Model?
Novartis puts the Development of two Anti-Aging Drugs in American Hands
Find your Perfect Job Match in the Biotech Industry! Maybe it’s Novozymes or CureVac!?
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
What Happened to the Smart Contact Lens for Diabetics?
Labiotech UG, All Rights Reserved -
Send this to friend